Literature DB >> 3897448

IgG bearing covalently bound C3b has enhanced bactericidal activity for Escherichia coli 0111.

K A Joiner, L F Fries, M A Schmetz, M M Frank.   

Abstract

The mechanism was sought by which bactericidal IgG for E. coli 0111 (strain 12015) increases the bactericidal efficiency of C5b-9. IgG did not affect the distribution of C3 deposition on the O-Ag capsule and the outer membrane of 12015, suggesting that bactericidal IgG was not directing complement activation to different sites on the bacterial surface. However, one-fifth of the C3 that was deposited in the presence of IgG attached covalently to the antibody molecule. Covalent complexes between purified C3b and IgG were prepared in order to study the role of C3b-IgG in the bactericidal reaction. 8-10-fold less C3b-IgG than IgG was necessary to sensitize 12015 for serum killing. When aggregates were eliminated from the C3b-IgG and IgG preparations by sucrose density gradient ultracentrifugation, C3b-IgG remained three- to fourfold more effective than IgG on a molecule-for-molecule bound basis in mediating the serum bactericidal reaction. These results suggest that formation of C3b-IgG during the serum bactericidal reaction is critical for killing, and have important implications for the development of effective bactericidal vaccines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897448      PMCID: PMC2187805          DOI: 10.1084/jem.162.3.877

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  C3 requirements for formation of alternative pathway C5 convertase.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

2.  The mechanism of complement fixation by rabbit F(ab')2: properties of the bactericidal reaction.

Authors:  E J Steele; D Rowley
Journal:  Immunochemistry       Date:  1977-05

3.  The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

Authors:  K J Gadd; K B Reid
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

4.  Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.

Authors:  F D Moore; K F Austen; D T Fearon
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

5.  The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.

Authors:  H A Schenkein; S Ruddy
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

6.  IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.

Authors:  F D Moore; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

7.  The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.

Authors:  P I Tarr; S W Hosea; E J Brown; R Schneerson; A Sutton; M M Frank
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

8.  Large scale isolation of functionally active components of the human complement system.

Authors:  C H Hammer; G H Wirtz; L Renfer; H D Gresham; B F Tack
Journal:  J Biol Chem       Date:  1981-04-25       Impact factor: 5.157

9.  The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.

Authors:  A W Hill; A L Shears; K G Hibbitt
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

10.  C3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.

Authors:  L F Fries; T A Gaither; C H Hammer; M M Frank
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  14 in total

1.  Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3.

Authors:  D Pilz; T Vocke; J Heesemann; V Brade
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

Review 2.  Molecular basis for serum resistance in Neisseria gonorrhoeae.

Authors:  P A Rice
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

3.  Interactions of monomeric IgG bearing covalently bound C3b with polymorphonuclear leucocytes.

Authors:  A Malbran; M M Frank; L F Fries
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

4.  Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae.

Authors:  K A Joiner; R Scales; K A Warren; M M Frank; P A Rice
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

5.  Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.

Authors:  Dan M Granoff; Isabella Costa; Monica Konar; Serena Giuntini; Koen K A Van Rompay; Peter T Beernink
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

6.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes.

Authors:  R K Gupta; W Egan; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes.

Authors:  L F Fries; S A Siwik; A Malbran; M M Frank
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

Review 9.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

10.  Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.

Authors:  S K Kochi; R C Johnson; A P Dalmasso
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.